bpc-157 peptide evidence human clinical trials safety The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and BPC-157 as an Investigational Peptide
Description
Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study
Bone 24 (3), 195202
Brain 141 , 357364 (2018)
First, we boil the water just like before
